Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) Income from Continuing Operations (2018 - 2026)

TransMedics has reported Income from Continuing Operations over the past 8 years, most recently at 18581000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 165.79% year-over-year to 18581000.0; the TTM value through Dec 2025 reached 103464000.0, up 28481.22%, while the annual FY2025 figure was 1114000.0, 207.73% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 18581000.0 at TransMedics, down from 24319000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 34882000.0 in Q2 2025 and troughed at 28245000.0 in Q4 2024.
  • A 5-year average of 3402200.0 and a median of 1818500.0 in 2023 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: crashed 242.34% in 2023 and later skyrocketed 1318.18% in 2024.
  • Year by year, Income from Continuing Operations stood at 31653000.0 in 2021, then crashed by 121.23% to 6720000.0 in 2022, then surged by 537.53% to 29402000.0 in 2023, then crashed by 196.06% to 28245000.0 in 2024, then skyrocketed by 165.79% to 18581000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for TMDX at 18581000.0 in Q4 2025, 24319000.0 in Q3 2025, and 34882000.0 in Q2 2025.